News for 'drug money'

Drug makers told to give pricing details in 10 days

Drug makers told to give pricing details in 10 days

Rediff.com6 Jun 2014

The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.

WHO drops Cipla: HIV drug list

WHO drops Cipla: HIV drug list

Rediff.com16 Jun 2004

The World Health Organisation has excluded two generic antiretroviral drugs of Cipla from its list of approved HIV medicines used more often in poor countries.

MNCs' diabetes drug patents worry experts

MNCs' diabetes drug patents worry experts

Rediff.com28 Feb 2008

Even as India is fast turning into the diabetes capital of the world, multinational drug companies are busy patenting new-generation diabetes medicines for exclusive marketing rights in the country.

Depp Vs Heard Review: Trashy Gossip!

Depp Vs Heard Review: Trashy Gossip!

Rediff.com18 Aug 2023

If there is one lesson we get from Depp vs Heard, it is that the American legal system is deeply flawed and the court of public opinion and social media make it harder for victims to get justice, observes Aseem Chhabra.

Sun Pharma gets USFDA nod for epilepsy drug

Sun Pharma gets USFDA nod for epilepsy drug

Rediff.com17 Jun 2010

Drug maker Sun Pharmaceutical Industries on Thursday said it has received the US health regulator's nod for marketing a generic version of the Keppra injection, used for treating epilepsy, in the American market.

Ranbaxy drugs cleared FDA test before import alert

Ranbaxy drugs cleared FDA test before import alert

Rediff.com11 Jun 2013

FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.

India could be 'efficacy test' for TB drug okayed by US

India could be 'efficacy test' for TB drug okayed by US

Rediff.com17 Mar 2013

There are also lingering concerns over the culture of misuse of pharmaceutical products in India, which has, in the past, led to other drugs becoming increasingly ineffective.

As drug firms squirm, authorities look abroad for cure

As drug firms squirm, authorities look abroad for cure

Rediff.com23 Sep 2013

DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices

How free drug policy will redefine health insurance

How free drug policy will redefine health insurance

Rediff.com17 Jul 2012

Insurers may be burning their fingers in urban health portfolios for some time now, but the government's rural healthcare initiatives, including its decision to provide free generic drugs to public hospitals, are set to offer fresh avenues of growth for them.

Wockhardt receives US nod for cardiac drug

Wockhardt receives US nod for cardiac drug

Rediff.com23 Jul 2010

Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug.

Court allows Cipla to market disputed drug

Court allows Cipla to market disputed drug

Rediff.com20 Mar 2008

The interim order was passed by the court on Wednesday on a plea filed by Roche Scientific on January 19 this year. The generic name of the drug is Erlotnib, which Roche markets as Tarceva and Cipla as Erlocip. Ahead of the next hearing, the court has asked Cipla to maintain records of sales of Erlocip.

Safin to Agassi: Give back titles and prize money

Safin to Agassi: Give back titles and prize money

Rediff.com10 Nov 2009

Marat Safin has come up with an instant remedy to help Andre Agassi clear his conscience after his admission that he lied about using drugs - hand back the millions of dollars he made in prize money.

Ranbaxy resumes drug exports to US after 4 years

Ranbaxy resumes drug exports to US after 4 years

Rediff.com2 Apr 2012

The firm, however, said the anti-cholesterol tablets meant for the US market will be produced at its Mohali SEZ plant in Punjab and not at the three units banned by the US health regulator.

SRK pays just tribute to Big B's Don

SRK pays just tribute to Big B's Don

Rediff.com20 Oct 2006

All essential drugs may come under price control

All essential drugs may come under price control

Rediff.com15 Jul 2010

The Union ministry of chemicals and fertilisers has initiated a move to bring all essential medicines sold in the country under a price cap.

Messiah of the masses: Cipla's global crusade for low cost drugs

Messiah of the masses: Cipla's global crusade for low cost drugs

Rediff.com24 Dec 2014

Drug maker Cipla always fought a lone battle to make drugs affordable in India.

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Rediff.com22 Aug 2022

'Gift-giving' - from free dinners and drug samples to promotional merchandise - seems to be driving drugmakers' marketing - a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical (pharma) companies 'gifting' doctors to push their respective drugs under the guise of marketing. But is there a cure in sight to end this unhealthy alliance? The recent controversy following the income-tax raids on Bengaluru-based drugmaker Micro Labs, makers of popular paracetamol brand Dolo-650, has brought this to the fore, again.

Twenty-five essential drugs to see 90% decline in prices

Twenty-five essential drugs to see 90% decline in prices

Rediff.com6 Jul 2013

The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines

Paswan promises to cut drug prices

Paswan promises to cut drug prices

Rediff.com21 Jun 2004

Union Minister for Chemicals and Fertilisers Ram Vilas Paswan said on Monday that his ministry would cut the prices of life saving and other important drugs by bringing more drugs under the 'price monitoring system' and also check the manufacture and

Exports dip 2.6% in Sep; trade deficit narrows to $19.37 bn

Exports dip 2.6% in Sep; trade deficit narrows to $19.37 bn

Rediff.com13 Oct 2023

Exports contracted by 2.6 per cent to $34.47 billion in September even as the country's merchandise trade deficit narrows to $19.37 billion during the month under review, according to the government data released on Friday. Easing commodity prices helped in cutting down the country's import bill by 15 per cent to $53.84 billion in September, the 10th consecutive month of decline. During April-September this fiscal, exports contracted by 8.77 per cent to $211.4 billion.

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

Dr Reddy's launch generic cancer drug in US market

Dr Reddy's launch generic cancer drug in US market

Rediff.com12 Jul 2013

The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration of Dr Reddy's abbreviated new drug applications, it said in a statement.

Patent office rejects Roche claim on eye drug

Patent office rejects Roche claim on eye drug

Rediff.com6 May 2010

Swiss drug multinational Roche AG suffered yet another setback in its ongoing patent fights in India after the Chennai patent office rejected its claim over Valcyte (valganciclovir).

Regulator revises prices of 130 drugs

Regulator revises prices of 130 drugs

Rediff.com3 Aug 2007

In a decision that would impact the entire pharmaceutical industry, the National Pharmaceutical Pricing Authority (NPPA) has fixed the prices of 130 common drugs and antibiotics.

Nicholas Piramal develops drug leads from Antarcti

Nicholas Piramal develops drug leads from Antarcti

Rediff.com29 Jun 2007

Indian drug major Nicholas Piramal India Ltd is likely to be among the first pharmaceutical companies worldwide to develop drugs isolated from the flora and fauna of Antarctica.

Will India's Covaxin be world's first COVID-19 drug?

Will India's Covaxin be world's first COVID-19 drug?

Rediff.com3 Jul 2020

'We need to prove to the world that quality vaccines and R&D are possible in India.'

'Price control hinders fight against fake drugs'

'Price control hinders fight against fake drugs'

Rediff.com21 Aug 2007

Price control of drugs in India is making it difficult for companies to fight against spurious medicines as they are unable to set off the resultant increase in cost, Nicolas Piramal director Swati Piramal said on Tuesday.

Beware! 12% drugs are substandard

Beware! 12% drugs are substandard

Rediff.com26 Sep 2003

Around 12 per cent of the drugs sold in the open market across the country are "sub-standard" and over 0.5 per cent are "spurious," a senior official of Union health ministry said in Lucknow.

Dr Reddy's plans to brand US speciality drugs

Dr Reddy's plans to brand US speciality drugs

Rediff.com25 Aug 2008

Dr Reddy's Laboratories plans to brand its speciality drugs sold in the US. It will begin selling branded skin care products by year-end. The venture will be spearheaded by Promius Pharma, a wholly owned subsidiary of its US arm

Cymbiotics, Elder Pharma sign 3 drug deal

Cymbiotics, Elder Pharma sign 3 drug deal

Rediff.com29 May 2007

Cymbiotics, a US-based bio-pharmaceutical manufacturer, has entered into a joint in-licensing agreement with Elder Pharmaceuticals to manufacture and market three of its drugs for pain management, diabetes and dermatology in the Indian market.

3 Indian pharma cos recall products in US market

3 Indian pharma cos recall products in US market

Rediff.com24 Apr 2022

Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Pharma is recalling a drug used to increase the production of natural tears in eyes. Similarly, Jubilant Cadista is recalling a drug which is used to treat different inflammatory conditions.

India battles HIV/AIDS drug shortage as some firms halt supply

India battles HIV/AIDS drug shortage as some firms halt supply

Rediff.com4 Sep 2014

India had the third-largest number of people living with HIV in the world at the end of 2013 and accounts for about four out of 10 people living with HIV in the Asian region.

Ranbaxy shares jump on drug approval in US

Ranbaxy shares jump on drug approval in US

Rediff.com27 Jun 2014

Earlier in April, Sun Pharmaceuticals Industries announced acquisition of Ranbaxy in an all-share deal.

Essential drugs go missing from counter on low margins

Essential drugs go missing from counter on low margins

Rediff.com4 Sep 2013

Medicines, including antibiotics, contraceptives and anti-diabetic drugs, were found to be out of stock at various places around Delhi.

Ranbaxy gets Canada nod to market cholesterol drug

Ranbaxy gets Canada nod to market cholesterol drug

Rediff.com21 Jul 2009

The company's Canadian subsidiary Ranbaxy Pharmaceuticals -- Canada Inc has received final approval from TPD to manufacture and market Ran-Simvastatin tablets, the Gurgaon-headquartered pharma major said in a statement. The approval for Ran-Simvastatin tablets, which are used as a lipid metabolism regulator, is in the strength of 5, 10, 20, 40 and 80 mg.

Our current drugs in India, global markets safe: Ranbaxy

Our current drugs in India, global markets safe: Ranbaxy

Rediff.com31 May 2013

The company's move follows reports of a circular by Mumbai's Jaslok Hospital, that put restrictions on prescribing Ranbaxy Laboratories products.

Govt to reduce cancer drug prices soon

Govt to reduce cancer drug prices soon

Rediff.com3 Dec 2009

Replying to supplementaries during Question Hour in the Lok Sabha, minister of state for chemicals and fertilisers Srikant Jena said the National Pharmaceutical Pricing Authority has been asked to look into demands for bringing 23 anti-cancer drugs within the ambit of price control.

Israel trade with India doubled after Covid-19 pandemic

Israel trade with India doubled after Covid-19 pandemic

Rediff.com16 Oct 2023

India's trade ties with Israel have only strengthened in the years after 2019. The total value of trade rose to $10.5 billion on a rolling four-quarter basis in June 2023 from $5.5 billion in the same month in 2019, shows a Business Standard analysis of data from the Centre for Monitoring Indian Economy (CMIE). A rolling four-quarter number provides a comparable figure across different time periods.